Patent 7273604 was granted and assigned to Britannia Pharmaceuticals on September, 2007 by the United States Patent and Trademark Office.
Disclosed is a combination product for use in treating asthma and other respiratory conditions comprising a medicament comprising a surface active phospholipid composition in the form of a fine powder and an antiasthma drug. The product is arranged to be administered to the lungs by inhalation, for example, by the disclosed devices.